Hält derzeit Positionen bei IDEXX Laboratories Inc and GlycoMimetics Inc
Position | Company | Period |
---|---|---|
Independent Director | IDEXX Laboratories Inc | 11. März 2014 - |
Independent Director | GlycoMimetics Inc | 17. März 2016 - |
Independent Director | Vitae Pharmaceuticals LLC | 27. Juli 2016 - 25. Oktober 2016 |
President, Chief Executive Officer, Director | ImmunoGen Inc | 30. Dezember 2013 - 16. Mai 2016 |
President, Chief Executive Officer, Interim Chief Financial Officer, Director | ImmunoGen Inc | 13. September 2013 - 30. Dezember 2013 |
President, Chief Executive Officer, Director | ImmunoGen Inc | 1. Januar 2009 - 13. September 2013 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-05-11 | 2023-05-10 |
GlycoMimetics Inc
(GLYC)
|
K Kauf |
30.000
+47.4%
1,5646.800 USD |
30.000 +47.4% | 1,56 | 46.800 USD | |
2023-02-17 | 2023-02-16 |
IDEXX Laboratories Inc
(IDXX)
|
V Verkauf |
2.187
-42.3%
511,681.119.044 USD |
2.187 -42.3% | 511,68 | 1.119.044 USD | |
2022-12-07 | 2022-12-05 |
IDEXX Laboratories Inc
(IDXX)
|
V Verkauf |
3.046
-50.6%
424,911.294.276 USD |
3.046 -50.6% | 424,91 | 1.294.276 USD | |
2022-11-18 | 2022-11-17 |
GlycoMimetics Inc
(GLYC)
|
K Kauf |
20.000
+46.2%
1,8737.400 USD |
20.000 +46.2% | 1,87 | 37.400 USD | |
2021-05-24 | 2021-05-21 |
IDEXX Laboratories Inc
(IDXX)
|
V Verkauf |
2.500
-46.4%
539,571.348.918 USD |
2.500 -46.4% | 539,57 | 1.348.918 USD | |
2021-02-24 | 2021-02-22 |
IDEXX Laboratories Inc
(IDXX)
|
V Verkauf |
1.888
-39.6%
538,571.016.815 USD |
1.888 -39.6% | 538,57 | 1.016.815 USD | |
2021-02-24 | 2021-02-22 |
IDEXX Laboratories Inc
(IDXX)
|
V Verkauf |
10
-0.2%
539,195.392 USD |
10 -0.2% | 539,19 | 5.392 USD | |
2020-08-21 | 2020-08-20 |
IDEXX Laboratories Inc
(IDXX)
|
V Verkauf |
3.722
-56.7%
382,611.424.063 USD |
3.722 -56.7% | 382,61 | 1.424.063 USD | |
2020-03-10 | 2020-03-09 |
GlycoMimetics Inc
(GLYC)
|
K Kauf |
20.000
+111.1%
3,4068.000 USD |
20.000 +111.1% | 3,40 | 68.000 USD | |
2019-08-15 | 2019-08-13 |
GlycoMimetics Inc
(GLYC)
|
K Kauf |
10.000
+125.0%
3,1831.800 USD |
10.000 +125.0% | 3,18 | 31.800 USD | |
2016-12-21 | 2016-12-20 |
GlycoMimetics Inc
(GLYC)
|
K Kauf |
5.000
+inf%
6,0130.050 USD |
5.000 +inf% | 6,01 | 30.050 USD |